Overview

The OBSTACLE Hypoglycemia Study (MK-0000-158)

Status:
Completed

Trial end date:
2010-05-01

Target enrollment:

Participant gender:

Summary

This study will assess the correlation between glycemic control and the hypoglycemia symptom score in patients with Type 2 diabetes, 12 weeks after addition of a sulfonylurea to an ongoing regime of oral hypoglycemic agents.

Details

Lead Sponsor:

Merck Sharp & Dohme Corp.